Because HGF may increase EGFR-TKI resistance, PD-L1 expression, and immune escape in NSCLC, we explored the regulatory mechanisms of PD-L1 expression in HGF-mediated EGFR-TKI resistant NSCLC tumours. This evidence concerns the gene EGFR and non-small cell lung carcinoma.